Your browser is no longer supported. Please, upgrade your browser.
Settings
UBX Unity Biotechnology, Inc. daily Stock Chart
UBX [NASD]
Unity Biotechnology, Inc.
Index- P/E- EPS (ttm)-6.43 Insider Own0.20% Shs Outstand42.43M Perf Week-1.48%
Market Cap339.86M Forward P/E- EPS next Y-2.22 Insider Trans- Shs Float37.62M Perf Month-9.08%
Income-76.40M PEG- EPS next Q-0.52 Inst Own71.40% Short Float14.39% Perf Quarter-47.54%
Sales- P/S- EPS this Y-153.60% Inst Trans1.68% Short Ratio31.07 Perf Half Y-36.48%
Book/sh3.85 P/B2.08 EPS next Y8.60% ROA-41.90% Target Price25.40 Perf Year-
Cash/sh4.03 P/C1.99 EPS next 5Y- ROE-70.00% 52W Range7.39 - 24.56 Perf YTD-50.74%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-67.39% Beta-
Dividend %- Quick Ratio10.40 Sales past 5Y- Gross Margin- 52W Low8.39% ATR0.62
Employees106 Current Ratio10.40 Sales Q/Q- Oper. Margin- RSI (14)41.30 Volatility7.96% 7.63%
OptionableYes Debt/Eq0.00 EPS Q/Q-75.20% Profit Margin- Rel Volume0.75 Prev Close7.85
ShortableYes LT Debt/Eq0.00 EarningsMar 06 AMC Payout- Avg Volume174.18K Price8.01
Recom2.00 SMA20-1.69% SMA50-14.04% SMA200-40.05% Volume131,021 Change2.04%
Mar-07-19Initiated Cantor Fitzgerald Overweight $21
Sep-07-18Initiated Mizuho Buy
May-29-18Initiated Morgan Stanley Overweight $25
May-29-18Initiated Goldman Neutral $17
May-29-18Initiated Citigroup Buy $32
Mar-06-19 08:00AM  UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Program Updates GlobeNewswire -11.15%
Mar-04-19 04:05PM  UNITY Biotechnology, Inc. to Participate in the Cowen 39th Annual Health Care Conference GlobeNewswire
Feb-27-19 04:05PM  CORRECTING and REPLACING -- UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Feb-25-19 04:05PM  UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Jan-23-19 07:22AM  The Daily Biotech Pulse: PTC Therapeutics, Select Biosciences Offering, Unity Biotech Expands Early-Stage Osteoarthritis Drug Study Benzinga
Jan-22-19 04:05PM  UNITY Biotechnology Expands Ongoing UBX0101 Phase 1 Study to Further Evaluate SASP Factors in Osteoarthritis of the Knee GlobeNewswire
Jan-08-19 07:00AM  Ascentage Pharma Announces New License with Unity Biotechnology PR Newswire
Jan-03-19 04:52PM  UNITY Biotechnology Announces Completion of UBX1967 License and Advance into IND-Enabling Studies for Age-Related Diseases of the Eye GlobeNewswire
Dec-05-18 10:35AM  This year's Bay Area IPO batch remains up 44% despite market turbulence American City Business Journals
08:46AM  UNITY (UBX) Soars: Stock Adds 5.1% in Session Zacks
Dec-04-18 08:00AM  UNITY Biotechnology, Inc. Appoints Margo Roberts Ph.D. to Board of Directors GlobeNewswire +5.05%
07:59AM  The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO Benzinga
Dec-03-18 05:30PM  UNITY Biotechnology Announces Additional Cohort to Evaluate Higher Dose in Ongoing UBX0101 Phase 1 Study in Osteoarthritis of the Knee GlobeNewswire +6.30%
Nov-13-18 08:00AM  UNITY Biotechnology, Inc. to Host Investor & Analyst Event on Cellular Senescence GlobeNewswire
Nov-07-18 04:05PM  UNITY Biotechnology, Inc. Reports Third Quarter 2018 Financial Results GlobeNewswire
Oct-31-18 04:05PM  UNITY Biotechnology, Inc. to Announce Third Quarter 2018 Financial Results GlobeNewswire
Oct-01-18 01:34PM  24 Bay Area companies have gone public so far this year. Here's how they've done. American City Business Journals
Sep-24-18 04:05PM  UNITY Biotechnology, Inc. to Participate in the Cantor Fitzgerald Annual Global Healthcare Conference GlobeNewswire
Sep-20-18 02:59PM  Do You Know Who Else Invests In Unity Biotechnology Inc (NASDAQ:UBX)? Simply Wall St.
Sep-17-18 08:00AM  Todays Research Reports on Stocks to Watch: Unity Biotechnology and Principia Biopharma ACCESSWIRE
Sep-14-18 09:53AM  Unity (UBX) Catches Eye: Stock Jumps 8.8% Zacks +10.00%
Sep-13-18 02:46PM  Unity Biotech CEO: We can 'absolutely' create drugs that slow, halt or reverse diseases of aging CNBC +8.81%
Sep-05-18 04:05PM  UNITY Biotechnology, Inc. to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference GlobeNewswire
Aug-29-18 09:39AM  Why Jeff Bezos is backing this Silicon Valley scientist who is working on a cure for aging CNBC
Aug-09-18 04:05PM  UNITY Biotechnology, Inc. Reports Second Quarter 2018 Financial Results GlobeNewswire
Jul-31-18 04:05PM  UNITY Biotechnology, Inc. to Announce Second Quarter 2018 Financial Results GlobeNewswire
Jul-13-18 02:45PM  Here are Q2's 10 biggest VC-backed exits from the Bay Area American City Business Journals
Jun-25-18 08:00AM  UNITY Biotechnology, Inc. Announces First Patient Treated in UBX0101 Phase 1 Trial for Osteoarthritis of the Knee GlobeNewswire
Jun-13-18 04:00PM  UNITY Biotechnology, Inc. Added to Russell 3000®, 2000® and MicroCap® Indexes GlobeNewswire
07:20AM  Wired News Alexion Pharma and Complement Pharma Inked Deal to Co-develop Preclinical C6 Complement Inhibitor CP010 ACCESSWIRE
Jun-07-18 05:00PM  UNITY Biotechnology, Inc. Reports First Quarter 2018 Financial Results GlobeNewswire
Jun-05-18 04:05PM  UNITY Biotechnology, Inc. to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference GlobeNewswire
10:00AM  A Biotech Entrepreneur Aims To Help Us Stay Young While Growing Old Forbes
May-29-18 04:05PM  UNITY Biotechnology, Inc. to Announce First Quarter 2018 Financial Results GlobeNewswire
04:04PM  Unity Biotech Is A Buy On 'Novel Biology,' Morgan Stanley Says In Positive Initiation Benzinga
May-14-18 04:05PM  UNITY Biotechnology, Inc. Appoints Camille Landis as Senior Vice President of Corporate Development GlobeNewswire
10:32AM  3 New Healthcare Stocks to Buy Right Now InvestorPlace
May-07-18 04:05PM  UNITY Biotechnology, Inc. Announces Closing of Initial Public Offering GlobeNewswire
May-04-18 12:45AM  [$$] ARCH-backed Unity Bio Ends Lower in IPO The Wall Street Journal
May-03-18 04:37PM  Unity Biotech Shares Open For Trade Benzinga
May-02-18 07:10PM  UNITY Biotechnology, Inc. Announces Pricing of Initial Public Offering of Common Stock GlobeNewswire
12:45PM  [$$] Longevity Startups Come of Age The Wall Street Journal
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to extend human health span. The company's lead drug candidates include UBX0101 that is in Phase 1 clinical study for musculoskeletal disease; and UBX1967 for ophthalmologic diseases. It is also developing programs in pulmonary disorders. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was founded in 2009 and is headquartered in Brisbane, California.